NCT06525220 2026-02-23A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)Merus B.V.Phase 3 Recruiting500 enrolled
NCT05386550 2026-02-19Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)EMD SeronoPhase 3 Terminated166 enrolled 15 charts
NCT00198328 2022-03-04Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell CarcinomaInovio PharmaceuticalsPhase 3 Terminated84 enrolled
NCT00101582 2016-09-27Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck CancerSwedish Orphan BiovitrumPhase 3 Completed188 enrolled 19 charts
NCT00128817 2013-01-23Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal CancersTata Memorial HospitalPhase 3 Terminated900 enrolled
NCT00094081 2010-02-15Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck CancerSanofiPhase 3 Completed861 enrolled
NCT00050388 2008-06-24Phase II Trial of Allovectin-7® for Head and Neck CancerVicalPhase 3 Completed